Giancarlo Agnelli Selected Research

Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)

1/2016	Serum cholesterol levels, HMG-CoA reductase inhibitors and the risk of intracerebral haemorrhage. The Multicenter Study on Cerebral Haemorrhage in Italy (MUCH-Italy).
1/2011	Gene-drug interaction in stroke.
9/2007	Comparison of utilization of statin therapy at hospital discharge and six-month outcomes in patients with an acute coronary syndrome and serum low-density lipoprotein>or=100 mg/dl versus<100 mg/dl.
1/2007	Statins and stroke prevention.
6/2005	Impact of combined pharmacologic treatment with clopidogrel and a statin on outcomes of patients with non-ST-segment elevation acute coronary syndromes: perspectives from a large multinational registry.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Giancarlo Agnelli Research Topics

Disease

99	Hemorrhage 01/2024 - 07/2002
92	Venous Thromboembolism 01/2024 - 03/2002
67	Neoplasms (Cancer) 01/2024 - 03/2002
54	Stroke (Strokes) 10/2023 - 01/2004
46	Atrial Fibrillation 10/2023 - 01/2004
41	Pulmonary Embolism 12/2023 - 12/2002
36	Venous Thrombosis (Deep-Vein Thrombosis) 01/2023 - 10/2003
26	Thrombosis (Thrombus) 10/2023 - 01/2002
26	Ischemic Stroke 01/2022 - 01/2007
11	Acute Coronary Syndrome 08/2015 - 01/2005
6	Myocardial Infarction 01/2020 - 01/2004
6	Embolism (Embolus) 12/2019 - 03/2012
5	Cardiovascular Diseases (Cardiovascular Disease) 06/2023 - 06/2007
5	Gastrointestinal Neoplasms (Gastrointestinal Cancer) 01/2023 - 01/2020
5	Thrombocytopenia (Thrombopenia) 05/2021 - 07/2002
5	Body Weight (Weight, Body) 05/2021 - 10/2011
5	Cerebral Hemorrhage 01/2021 - 01/2007
4	Hematoma 01/2020 - 08/2008
4	Embolic Stroke 01/2019 - 02/2007
4	Heart Diseases (Heart Disease) 01/2019 - 01/2007
4	Thromboembolism 04/2016 - 01/2005
4	Transient Ischemic Attack 08/2015 - 01/2007
4	ST Elevation Myocardial Infarction 06/2010 - 06/2005
3	Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome) 10/2023 - 01/2020
3	Colorectal Neoplasms (Colorectal Cancer) 01/2022 - 09/2017
3	Shock 11/2020 - 07/2007
3	Vascular Diseases (Vascular Disease) 08/2015 - 01/2007
3	Clinical Deterioration 11/2013 - 10/2008
3	Hemorrhagic Stroke 01/2013 - 11/2009
3	Unstable Angina 06/2007 - 07/2002
2	Peripheral Arterial Disease 06/2023 - 07/2007
2	Urogenital Neoplasms 01/2023 - 05/2022
2	Renal Insufficiency (Renal Failure) 01/2022 - 01/2020
2	Brain Neoplasms (Brain Tumor) 01/2022 - 05/2021
2	Lung Neoplasms (Lung Cancer) 10/2020 - 01/2018
2	Infections 12/2019 - 01/2013
2	Hypertension (High Blood Pressure) 11/2019 - 01/2012
2	Brain Ischemia (Cerebral Ischemia) 01/2019 - 03/2012
2	Wounds and Injuries (Trauma) 10/2016 - 06/2002
2	Right Ventricular Dysfunction 04/2014 - 11/2013

Drug/Important Bio-Agent (IBA)

124	AnticoagulantsIBA 01/2024 - 07/2003
31	Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA 06/2023 - 07/2002
27	Heparin (Liquaemin)FDA LinkGeneric 01/2023 - 07/2002
26	Vitamin K FDA Link 10/2023 - 01/2005
23	apixabanIBA 01/2024 - 03/2012
21	RivaroxabanIBA 01/2022 - 07/2007
18	Warfarin (Coumadin)FDA LinkGeneric 12/2020 - 07/2007
17	Enoxaparin (Lovenox)FDA LinkGeneric 11/2023 - 03/2002
12	Dalteparin (Dalteparin Sodium)FDA Link 01/2024 - 09/2018
11	edoxabanIBA 01/2022 - 07/2014
11	Factor Xa InhibitorsIBA 01/2022 - 07/2007
11	Dabigatran FDA Link 02/2020 - 05/2010
9	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 06/2023 - 06/2005
7	TroponinIBA 01/2021 - 07/2007
7	AntithrombinsIBA 06/2012 - 02/2003
6	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2022 - 01/2002
6	Tissue Plasminogen Activator (Alteplase)FDA Link 01/2021 - 01/2007
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2016 - 06/2005
5	Thrombin FDA Link 06/2013 - 01/2004
5	ximelagatran (Exanta)IBA 01/2006 - 02/2003
4	factor V LeidenIBA 01/2015 - 09/2002
4	Blood Glucose (Blood Sugar)IBA 03/2012 - 08/2008
4	melagatranIBA 01/2006 - 02/2003
3	CreatinineIBA 01/2023 - 01/2020
3	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2019 - 01/2013
3	LDL CholesterolIBA 01/2018 - 01/2007
3	LDL Lipoproteins (beta Lipoproteins)IBA 01/2018 - 01/2007
3	CholesterolIBA 01/2016 - 01/2007
3	Factor Xa (Coagulation Factor Xa)IBA 06/2013 - 04/2012
3	Biomarkers (Surrogate Marker)IBA 09/2012 - 01/2009
3	Fibrinolytic Agents (Antithrombotic Agents)IBA 04/2012 - 07/2002
3	Nadroparin (Nadroparin Calcium)IBA 10/2011 - 10/2009
3	Prothrombin (Factor II)IBA 05/2009 - 09/2002
3	Glycoproteins (Glycoprotein)IBA 01/2009 - 11/2005
2	Factor XI (Plasma Thromboplastin Antecedent)IBA 10/2023 - 01/2023
2	Hemoglobins (Hemoglobin)IBA 10/2021 - 11/2020
2	Antineoplastic Agents (Antineoplastics)IBA 01/2021 - 05/2014
2	Antihypertensive Agents (Antihypertensives)IBA 11/2019 - 01/2011
2	Progestins (Progestagens)IBA 06/2018 - 04/2008
2	oxidized low density lipoproteinIBA 01/2018 - 09/2007
2	semuloparinIBA 06/2014 - 02/2012
2	Tenecteplase FDA Link 04/2014 - 03/2010

Therapy/Procedure

65	Therapeutics 01/2024 - 07/2003
15	Drug Therapy (Chemotherapy) 01/2023 - 10/2003
11	Secondary Prevention 01/2022 - 01/2004
10	Length of Stay 01/2021 - 01/2007
9	Catheters 01/2023 - 06/2005
8	Thrombolytic Therapy 01/2020 - 08/2004
5	Central Venous Catheters 12/2019 - 10/2003
4	Duration of Therapy 07/2022 - 07/2003
4	Orthopedic Procedures 12/2017 - 07/2002
3	Percutaneous Coronary Intervention 10/2018 - 06/2010
3	Vena Cava Filters (Inferior Vena Cava Filter) 12/2016 - 02/2008
3	Hip Replacement Arthroplasty (Total Hip Replacement) 02/2014 - 07/2002
3	Subcutaneous Injections 10/2011 - 07/2002
2	Oral Administration 07/2021 - 09/2008
2	Contraindications 01/2020 - 06/2018
2	Activities of Daily Living (ADL) 01/2018 - 01/2012
2	Bed Rest (Bedrest) 09/2016 - 01/2006
2	Hormone Replacement Therapy (Therapy, Hormone Replacement) 01/2015 - 04/2008